世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

処方用プロトンポンプ阻害剤の世界市場に関する洞察、2028年までの予測


Global Prescription Proton Pump Inhibitor Market Insights, Forecast to 2028

プロトンポンプ阻害薬(PPI)は、胃酸の分泌を長時間にわたって抑制することを主作用とする薬物である。 市場分析および洞察。処方用プロトンポンプ阻害剤の世界市場 COVID-19の流行により、世界の処方用プロト... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年3月4日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

プロトンポンプ阻害薬(PPI)は、胃酸の分泌を長時間にわたって抑制することを主作用とする薬物である。
市場分析および洞察。処方用プロトンポンプ阻害剤の世界市場
COVID-19の流行により、世界の処方用プロトンポンプ阻害剤の市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR%で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に処方用プロトンポンプ阻害剤世界市場の%を占めたランソプラゾールは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された%のCAGRで成長すると予測されます。一方、病院分野は、この予測期間を通じて、年平均成長率(%)に変更されています。

2021年の中国処方型プロトンポンプ阻害剤の市場規模は百万米ドル、米国と欧州処方型プロトンポンプ阻害剤はそれぞれ百万米ドル、百万米ドルとなっています。2021年の米国の割合は%、中国と欧州はそれぞれ%と%であり、中国の割合は2028年には%に達すると予測され、分析期間を通じてCAGR%で推移しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパのPPI(プロトンポンプ阻害剤)市場については、ドイツが2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
処方用プロトンポンプ阻害剤の世界の主要メーカーには、AstraZeneca、Cadila Pharmaceuticals、Eisai、Eli Lilly、Janssen、Pfizer、Santarus、Wyethなどが含まれます。2021年、世界の上位5社は売上高で約 %のシェアを持っています。

世界の処方用プロトンポンプ阻害剤の範囲とセグメント
処方箋型プロトンポンプ阻害剤市場は、タイプ別および用途別に分類されます。世界の処方型プロトンポンプ阻害剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになることでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
ランソプラゾール
パントプラゾール
ラベプラゾール
その他
用途別セグメント
病院
研究室
その他

会社別
アストラゼネカ
カディラ・ファーマシューティカルズ
エーザイ
イーライ・リリー
ヤンセン
ファイザー
サンタラス社
ワイス

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Prescription Proton Pump Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lansoprazole
1.2.3 Pantoprazole
1.2.4 Rabeprazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Proton Pump Inhibitor Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Proton Pump Inhibitor Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Proton Pump Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Proton Pump Inhibitor Sales by Region
2.4.1 Global Prescription Proton Pump Inhibitor Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Proton Pump Inhibitor by Region (2023-2028)
2.5 Global Prescription Proton Pump Inhibitor Revenue by Region
2.5.1 Global Prescription Proton Pump Inhibitor Revenue by Region (2017-2022)
2.5.2 Global Prescription Proton Pump Inhibitor Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Proton Pump Inhibitor Sales by Manufacturers
3.1.1 Global Top Prescription Proton Pump Inhibitor Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Proton Pump Inhibitor Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Proton Pump Inhibitor in 2021
3.2 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers
3.2.1 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Proton Pump Inhibitor Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Proton Pump Inhibitor Revenue in 2021
3.3 Global Prescription Proton Pump Inhibitor Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Proton Pump Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Proton Pump Inhibitor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Proton Pump Inhibitor Sales by Type
4.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Type (2017-2028)
4.2 Global Prescription Proton Pump Inhibitor Revenue by Type
4.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Proton Pump Inhibitor Price by Type
4.3.1 Global Prescription Proton Pump Inhibitor Price by Type (2017-2022)
4.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prescription Proton Pump Inhibitor Sales by Application
5.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Application (2017-2022)
5.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Application (2023-2028)
5.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Application (2017-2028)
5.2 Global Prescription Proton Pump Inhibitor Revenue by Application
5.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Application (2017-2022)
5.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Application (2017-2028)
5.3 Global Prescription Proton Pump Inhibitor Price by Application
5.3.1 Global Prescription Proton Pump Inhibitor Price by Application (2017-2022)
5.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Proton Pump Inhibitor Market Size by Type
6.1.1 North America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
6.1.2 North America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
6.2 North America Prescription Proton Pump Inhibitor Market Size by Application
6.2.1 North America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
6.2.2 North America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
6.3 North America Prescription Proton Pump Inhibitor Market Size by Country
6.3.1 North America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
6.3.2 North America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Prescription Proton Pump Inhibitor Market Size by Type
7.1.1 Europe Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
7.1.2 Europe Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
7.2 Europe Prescription Proton Pump Inhibitor Market Size by Application
7.2.1 Europe Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
7.2.2 Europe Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
7.3 Europe Prescription Proton Pump Inhibitor Market Size by Country
7.3.1 Europe Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
7.3.2 Europe Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Type
8.1.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Application
8.2.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
8.2.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
8.3 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Region
8.3.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prescription Proton Pump Inhibitor Market Size by Type
9.1.1 Latin America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
9.1.2 Latin America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
9.2 Latin America Prescription Proton Pump Inhibitor Market Size by Application
9.2.1 Latin America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
9.2.2 Latin America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
9.3 Latin America Prescription Proton Pump Inhibitor Market Size by Country
9.3.1 Latin America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
9.3.2 Latin America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Type
10.1.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Application
10.2.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
10.3 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Country
10.3.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Corporation Information
11.2.2 Cadila Pharmaceuticals Overview
11.2.3 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cadila Pharmaceuticals Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Overview
11.3.3 Eisai Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eisai Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Janssen
11.5.1 Janssen Corporation Information
11.5.2 Janssen Overview
11.5.3 Janssen Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Janssen Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Santarus
11.7.1 Santarus Corporation Information
11.7.2 Santarus Overview
11.7.3 Santarus Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Santarus Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Santarus Recent Developments
11.8 Wyeth
11.8.1 Wyeth Corporation Information
11.8.2 Wyeth Overview
11.8.3 Wyeth Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wyeth Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wyeth Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Proton Pump Inhibitor Industry Chain Analysis
12.2 Prescription Proton Pump Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Proton Pump Inhibitor Production Mode & Process
12.4 Prescription Proton Pump Inhibitor Sales and Marketing
12.4.1 Prescription Proton Pump Inhibitor Sales Channels
12.4.2 Prescription Proton Pump Inhibitor Distributors
12.5 Prescription Proton Pump Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Proton Pump Inhibitor Industry Trends
13.2 Prescription Proton Pump Inhibitor Market Drivers
13.3 Prescription Proton Pump Inhibitor Market Challenges
13.4 Prescription Proton Pump Inhibitor Market Restraints
14 Key Findings in The Global Prescription Proton Pump Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

Proton-pump inhibitors (PPIs) are members of a class of medications whose main action is a profound and prolonged reduction of stomach acid production.
Market Analysis and Insights: Global Prescription Proton Pump Inhibitor Market
Due to the COVID-19 pandemic, the global Prescription Proton Pump Inhibitor market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Lansoprazole accounting for % of the Prescription Proton Pump Inhibitor global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Prescription Proton Pump Inhibitor market size is valued at US$ million in 2021, while the US and Europe Prescription Proton Pump Inhibitor are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Prescription Proton Pump Inhibitor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Prescription Proton Pump Inhibitor include AstraZeneca, Cadila Pharmaceuticals, Eisai, Eli Lilly, Janssen, Pfizer, Santarus and Wyeth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Prescription Proton Pump Inhibitor Scope and Segment
Prescription Proton Pump Inhibitor market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Prescription Proton Pump Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Lansoprazole
Pantoprazole
Rabeprazole
Others
Segment by Application
Hospital
Laboratory
Others

By Company
AstraZeneca
Cadila Pharmaceuticals
Eisai
Eli Lilly
Janssen
Pfizer
Santarus
Wyeth

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Prescription Proton Pump Inhibitor Product Introduction
1.2 Market by Type
1.2.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lansoprazole
1.2.3 Pantoprazole
1.2.4 Rabeprazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Prescription Proton Pump Inhibitor Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Prescription Proton Pump Inhibitor Sales Estimates and Forecasts 2017-2028
2.2 Global Prescription Proton Pump Inhibitor Revenue Estimates and Forecasts 2017-2028
2.3 Global Prescription Proton Pump Inhibitor Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Prescription Proton Pump Inhibitor Sales by Region
2.4.1 Global Prescription Proton Pump Inhibitor Sales by Region (2017-2022)
2.4.2 Global Sales Prescription Proton Pump Inhibitor by Region (2023-2028)
2.5 Global Prescription Proton Pump Inhibitor Revenue by Region
2.5.1 Global Prescription Proton Pump Inhibitor Revenue by Region (2017-2022)
2.5.2 Global Prescription Proton Pump Inhibitor Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Prescription Proton Pump Inhibitor Sales by Manufacturers
3.1.1 Global Top Prescription Proton Pump Inhibitor Manufacturers by Sales (2017-2022)
3.1.2 Global Prescription Proton Pump Inhibitor Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Prescription Proton Pump Inhibitor in 2021
3.2 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers
3.2.1 Global Prescription Proton Pump Inhibitor Revenue by Manufacturers (2017-2022)
3.2.2 Global Prescription Proton Pump Inhibitor Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Prescription Proton Pump Inhibitor Revenue in 2021
3.3 Global Prescription Proton Pump Inhibitor Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Prescription Proton Pump Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Prescription Proton Pump Inhibitor Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Prescription Proton Pump Inhibitor Sales by Type
4.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Type (2017-2022)
4.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Type (2023-2028)
4.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Type (2017-2028)
4.2 Global Prescription Proton Pump Inhibitor Revenue by Type
4.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Type (2017-2022)
4.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Type (2023-2028)
4.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Type (2017-2028)
4.3 Global Prescription Proton Pump Inhibitor Price by Type
4.3.1 Global Prescription Proton Pump Inhibitor Price by Type (2017-2022)
4.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Prescription Proton Pump Inhibitor Sales by Application
5.1.1 Global Prescription Proton Pump Inhibitor Historical Sales by Application (2017-2022)
5.1.2 Global Prescription Proton Pump Inhibitor Forecasted Sales by Application (2023-2028)
5.1.3 Global Prescription Proton Pump Inhibitor Sales Market Share by Application (2017-2028)
5.2 Global Prescription Proton Pump Inhibitor Revenue by Application
5.2.1 Global Prescription Proton Pump Inhibitor Historical Revenue by Application (2017-2022)
5.2.2 Global Prescription Proton Pump Inhibitor Forecasted Revenue by Application (2023-2028)
5.2.3 Global Prescription Proton Pump Inhibitor Revenue Market Share by Application (2017-2028)
5.3 Global Prescription Proton Pump Inhibitor Price by Application
5.3.1 Global Prescription Proton Pump Inhibitor Price by Application (2017-2022)
5.3.2 Global Prescription Proton Pump Inhibitor Price Forecast by Application (2023-2028)
6 North America
6.1 North America Prescription Proton Pump Inhibitor Market Size by Type
6.1.1 North America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
6.1.2 North America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
6.2 North America Prescription Proton Pump Inhibitor Market Size by Application
6.2.1 North America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
6.2.2 North America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
6.3 North America Prescription Proton Pump Inhibitor Market Size by Country
6.3.1 North America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
6.3.2 North America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Prescription Proton Pump Inhibitor Market Size by Type
7.1.1 Europe Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
7.1.2 Europe Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
7.2 Europe Prescription Proton Pump Inhibitor Market Size by Application
7.2.1 Europe Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
7.2.2 Europe Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
7.3 Europe Prescription Proton Pump Inhibitor Market Size by Country
7.3.1 Europe Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
7.3.2 Europe Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Type
8.1.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
8.1.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
8.2 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Application
8.2.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
8.2.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
8.3 Asia Pacific Prescription Proton Pump Inhibitor Market Size by Region
8.3.1 Asia Pacific Prescription Proton Pump Inhibitor Sales by Region (2017-2028)
8.3.2 Asia Pacific Prescription Proton Pump Inhibitor Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Prescription Proton Pump Inhibitor Market Size by Type
9.1.1 Latin America Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
9.1.2 Latin America Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
9.2 Latin America Prescription Proton Pump Inhibitor Market Size by Application
9.2.1 Latin America Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
9.2.2 Latin America Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
9.3 Latin America Prescription Proton Pump Inhibitor Market Size by Country
9.3.1 Latin America Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
9.3.2 Latin America Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Type
10.1.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Type (2017-2028)
10.1.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Type (2017-2028)
10.2 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Application
10.2.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Application (2017-2028)
10.2.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Application (2017-2028)
10.3 Middle East and Africa Prescription Proton Pump Inhibitor Market Size by Country
10.3.1 Middle East and Africa Prescription Proton Pump Inhibitor Sales by Country (2017-2028)
10.3.2 Middle East and Africa Prescription Proton Pump Inhibitor Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Cadila Pharmaceuticals
11.2.1 Cadila Pharmaceuticals Corporation Information
11.2.2 Cadila Pharmaceuticals Overview
11.2.3 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Cadila Pharmaceuticals Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Cadila Pharmaceuticals Recent Developments
11.3 Eisai
11.3.1 Eisai Corporation Information
11.3.2 Eisai Overview
11.3.3 Eisai Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eisai Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eisai Recent Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Overview
11.4.3 Eli Lilly Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Eli Lilly Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Eli Lilly Recent Developments
11.5 Janssen
11.5.1 Janssen Corporation Information
11.5.2 Janssen Overview
11.5.3 Janssen Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Janssen Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Recent Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Overview
11.6.3 Pfizer Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Pfizer Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Pfizer Recent Developments
11.7 Santarus
11.7.1 Santarus Corporation Information
11.7.2 Santarus Overview
11.7.3 Santarus Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Santarus Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Santarus Recent Developments
11.8 Wyeth
11.8.1 Wyeth Corporation Information
11.8.2 Wyeth Overview
11.8.3 Wyeth Prescription Proton Pump Inhibitor Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Wyeth Prescription Proton Pump Inhibitor Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Wyeth Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Prescription Proton Pump Inhibitor Industry Chain Analysis
12.2 Prescription Proton Pump Inhibitor Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Prescription Proton Pump Inhibitor Production Mode & Process
12.4 Prescription Proton Pump Inhibitor Sales and Marketing
12.4.1 Prescription Proton Pump Inhibitor Sales Channels
12.4.2 Prescription Proton Pump Inhibitor Distributors
12.5 Prescription Proton Pump Inhibitor Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Prescription Proton Pump Inhibitor Industry Trends
13.2 Prescription Proton Pump Inhibitor Market Drivers
13.3 Prescription Proton Pump Inhibitor Market Challenges
13.4 Prescription Proton Pump Inhibitor Market Restraints
14 Key Findings in The Global Prescription Proton Pump Inhibitor Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(組織細胞機能薬)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る